NCT05123976View on ClinicalTrials.gov

Fasted Bioequivalence Study of 2 Olanzapine Film-coated Tablets, 5 mg, in Healthy, Adult Male and Female Subjects.

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

October 21, 2020

Primary Completion Date

November 30, 2020

Study Completion Date

November 30, 2020

Conditions
Pharmacokinetics
Interventions
DRUG

Olanzapine film-coated tablets 5 mg (JSC Farmak, Ukraine)

After an overnight fast of at least 10 hours, a 1 film-coated tablet was administered orally with 240 mL of water .

DRUG

Zyprexa® coated tablets 5 mg (Eli Lilly, Nederland B V)

After an overnight fast of at least 10 hours, a 1 film-coated tablet was administered orally with 240 mL of water .

Trial Locations (1)

10200

QUINTA-ANALYTICA s.r.o., Prague

All Listed Sponsors
lead

"Joint Stock Company Farmak"

INDUSTRY

NCT05123976 - Fasted Bioequivalence Study of 2 Olanzapine Film-coated Tablets, 5 mg, in Healthy, Adult Male and Female Subjects. | Biotech Hunter | Biotech Hunter